207 related articles for article (PubMed ID: 28789440)
1. TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.
Hao L; Du B; Xi X
Oncol Lett; 2017 Aug; 14(2):2153-2164. PubMed ID: 28789440
[TBL] [Abstract][Full Text] [Related]
2. TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
Lou M; Gao Z; Zhu T; Mao X; Wang Y; Yuan K; Tong J
Oncol Lett; 2020 Feb; 19(2):1400-1408. PubMed ID: 31966070
[TBL] [Abstract][Full Text] [Related]
3. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S
PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262
[TBL] [Abstract][Full Text] [Related]
5. Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis.
Guo J; Min K; Deng L
Medicine (Baltimore); 2021 Aug; 100(32):e26868. PubMed ID: 34397900
[TBL] [Abstract][Full Text] [Related]
6. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
[TBL] [Abstract][Full Text] [Related]
7. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
8. TRIM59: A potential diagnostic and prognostic biomarker in human tumors.
Jin Z; Liu L; Yu Y; Li D; Zhu X; Yan D; Zhu Z
PLoS One; 2021; 16(9):e0257445. PubMed ID: 34534244
[TBL] [Abstract][Full Text] [Related]
9. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
He R; Liu H
Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the RNA-binding motif protein 47 predicts poor prognosis in non-small-cell lung cancer.
Li R; Li H; Ge C; Fu Q; Li Z; Jin Y; Tan Q; Zhu Z; Zhang Z; Dong S; Li G; Song X
Oncol Lett; 2020 Apr; 19(4):3111-3122. PubMed ID: 32218862
[TBL] [Abstract][Full Text] [Related]
11. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
13. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53.
Liu R; Li H; Xu Y; Li X; Guo X; Shi J; Cui Y; Wang Z; Liu J
Oncol Lett; 2021 Jan; 21(1):6. PubMed ID: 33240412
[TBL] [Abstract][Full Text] [Related]
14. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
15. TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1.
Han T; Guo M; Gan M; Yu B; Tian X; Wang JB
Autophagy; 2018; 14(12):2035-2048. PubMed ID: 30231667
[TBL] [Abstract][Full Text] [Related]
16. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
Zhan W; Han T; Zhang C; Xie C; Gan M; Deng K; Fu M; Wang JB
PLoS One; 2015; 10(11):e0142596. PubMed ID: 26599082
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
18. Testes-specific protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer.
Qiao WL; Shi BW; Han YD; Tang HM; Lin J; Hu HY; Lin Q
Oncol Lett; 2018 Jun; 15(6):8796-8804. PubMed ID: 29805619
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer.
Wang M; Li P; Wan R; Liu X
Biomed Pharmacother; 2019 Apr; 112():108590. PubMed ID: 30784913
[TBL] [Abstract][Full Text] [Related]
20. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
